Evidence map›Paper›PMID 30105266›Full record

Trial reportBioMed research international2018

Select Biomarkers on the Day of Anterior Cruciate Ligament Reconstruction Predict Poor Patient-Reported Outcomes at 2-Year Follow-Up: A Pilot Study.

Christian Lattermann, Caitlin E-W Conley, Darren L Johnson, Emily K Reinke, Laura J Huston, Janet L Huebner, Ching-Heng Chou, Virginia B Kraus, Kurt P Spindler, Cale A Jacobs

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Christian LattermannBrigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA, USA.
Caitlin E-W ConleyUniversity of Kentucky, Lexington, KY, USA.
Darren L JohnsonUniversity of Kentucky, Lexington, KY, USA.
Emily K ReinkeVanderbilt University, Nashville, TN, USA.
Laura J HustonVanderbilt University, Nashville, TN, USA.ORCID 0000-0002-9901-7165
Janet L HuebnerDuke University, Durham, NC, USA.
Ching-Heng ChouDuke University, Durham, NC, USA.
Virginia B KrausDuke University, Durham, NC, USA.
Kurt P SpindlerCleveland Clinic Sports Health Center, Garfield Heights, OH, USA.
Cale A JacobsUniversity of Kentucky, Lexington, KY, USA.ORCID 0000-0002-9300-5550
Duke University · USUniversity of Kentucky · USVanderbilt University · USBrigham and Women's Hospital · USCleveland Clinic · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Clinical and Biochemical Predictors of Outcome after Knee Injury in Young PatientK23AR060275 · NIAMS · UNIVERSITY OF KENTUCKY · PI LATTERMANN, CHRISTIAN · 2012 to 2016
$566k
NCATS NIH HHS UL1 TR000117NIAMS NIH HHS K23 AR060275
6 · The paper itself

Abstract

backgroundThe majority of patients develop posttraumatic osteoarthritis within 15 years of anterior cruciate ligament (ACL) injury. Inflammatory and chondrodegenerative biomarkers have been associated with both pain and the progression of osteoarthritis; however, it remains unclear if preoperative biomarkers differ for patients with inferior postoperative outcomes. HYPOTHESIS/PURPOSE: The purpose of this pilot study was to compare biomarkers collected on the day of ACL reconstruction between patients with "good" or "poor" 2-year postoperative outcomes. We hypothesized that inflammatory cytokines and chondrodegenerative biomarker concentrations would be significantly greater in patients with poorer outcomes. STUDY

designProspective cohort design.

methods22 patients (9 females, 13 males; age = 19.5 ± 4.1 years; BMI = 24.1 ± 3.6 kg/m

resultsPatients that failed to reach the QOL PASS threshold after surgery (n = 6, 27%) had significantly greater sf interleukin-1 alpha (IL-1

conclusionThese pilot data suggest that initial biochemical changes after injury may be an indicator of poor outcomes that are not mitigated by surgical stabilization alone. Biological adjuvant treatment in addition to ACL reconstruction may be beneficial; however, these data should be used for hypothesis generation and more definitive randomized clinical trials are necessary.

Indexed as

Anterior Cruciate Ligament ReconstructionPatient Reported Outcome MeasuresAdolescentAdultAnterior Cruciate Ligament InjuriesBiomarkersFemaleFollow-Up StudiesHumansKnee InjuriesMalePilot ProjectsPrognosisProspective StudiesQuality of LifeTreatment OutcomeBiomarkers

Identifiers

PMID30105266
PMCPMC6076965
OpenAlexW2884526862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.